Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: advances and prospects in the development of animal models for vaccine and therapeutic research

Hum Vaccin Immunother. 2020 Dec 1;16(12):3043-3054. doi: 10.1080/21645515.2020.1807802. Epub 2020 Sep 11.

Abstract

SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), is suspected to have been first contracted via animal-human interactions; it has further spread across the world by efficient human-to-human transmission. Recent reports of COVID-19 in companion animals (dogs and cats) and wild carnivores such as tigers have created a dilemma regarding its zoonotic transmission. Although in silico docking studies, sequence-based computational studies, and experimental studies have shown the possibility of SARS-CoV-2 infection and transmission in cats, ferrets, and other domestic/wild animals, the results are not conclusive of infection under natural conditions. Identifying the potential host range of SARS-CoV-2 will not only help prevent the possibility of human-to-animal and animal-to-human transmission but also assist in identifying efficient animal models that can mimic the clinical symptoms, transmission potential, and pathogenesis of the disease. Such an efficient animal model will accelerate the process of development and evaluation of vaccines, immunotherapeutics, and other remedies for SARS-CoV-2.

Keywords: COVID-19; SARS-CoV-2; animal; animal model; coronavirus; therapeutics; vaccines.

Publication types

  • Review

MeSH terms

  • Animals
  • Animals, Domestic / virology
  • Animals, Wild / virology
  • Biomedical Research / trends*
  • COVID-19 / prevention & control*
  • COVID-19 / transmission
  • COVID-19 Vaccines / therapeutic use*
  • Disease Models, Animal*
  • Humans
  • Zoonoses / prevention & control*
  • Zoonoses / transmission

Substances

  • COVID-19 Vaccines

Grants and funding

No substantial funding to be stated.